Breast lesions: diagnosis by using proton MR spectroscopy at 1.5 and 3.0 T—systematic review and meta-analysis

PAT Baltzer, M Dietzel - Radiology, 2013 - pubs.rsna.org
Purpose To perform a systematic review and meta-analysis to estimate the diagnostic
performance of breast proton magnetic resonance (MR) spectroscopy in differentiating …

Magnetic resonance spectroscopy of the breast: current status

PJ Bolan - Magnetic Resonance Imaging Clinics, 2013 - mri.theclinics.com
Magnetic resonance (MR) spectroscopy is a noninvasive diagnostic modality that can
measure chemical information from a selected region in the body. MR imaging scanners are …

Proton magnetic resonance spectroscopy in oncology: the fingerprints of cancer?

R García-Figueiras, S Baleato-González… - Diagnostic and …, 2015 - pmc.ncbi.nlm.nih.gov
Abnormal metabolism is a key tumor hallmark. Proton magnetic resonance spectroscopy
(1H-MRS) allows measurement of metabolite concentration that can be utilized to …

The contribution of diffusion tensor imaging and magnetic resonance spectroscopy for the differentiation of breast lesions at 3T

I Tsougos, P Svolos, E Kousi, E Athanassiou… - Acta …, 2014 - journals.sagepub.com
Background Conventional breast magnetic resonance imaging (MRI), including dynamic
contrast-enhanced MR mammography (DCE-MRM), may lead to ambiguous diagnosis and …

Improved diagnostic accuracy in differentiating malignant and benign lesions using single-voxel proton MRS of the breast at 3 T MRI

S Suppiah, K Rahmat, MN Mohd-Shah, CA Azlan… - Clinical radiology, 2013 - Elsevier
Aim To investigate the diagnostic accuracy of single-voxel proton magnetic resonance
spectroscopy (SV 1 H MRS) by quantifying total choline-containing compounds (tCho) in …

Differential diagnosis between malignant and benign breast lesions using single-voxel proton MRS: a meta-analysis

D Cen, L Xu - Journal of cancer research and clinical oncology, 2014 - Springer
Objectives We aim to investigate the diagnostic capability of single-voxel proton MR
spectroscopy (MRS) for benign/malignant discrimination of focal breast lesions with a meta …

In vivo MR spectroscopy for breast cancer diagnosis

U Sharma, NR Jagannathan - BJR| Open, 2019 - academic.oup.com
Breast cancer is a significant health concern in females, worldwide. In vivo proton (1H) MR
spectroscopy (MRS) has evolved as a non-invasive tool for diagnosis and for biochemical …

Qualitative 3-T proton MR spectroscopy for the characterization of musculoskeletal neoplasms: update on diagnostic performance and indications

PA Gondim Teixeira, M Ledrich, F Kauffmann… - American Journal of …, 2017 - ajronline.org
OBJECTIVE. The objective of our study was to evaluate the diagnostic performance of
qualitative 3-T proton MR spectroscopy (1H-MRS) for the characterization of …

[HTML][HTML] Proton magnetic resonance spectroscopy of the central nervous system

E Kousi, I Tsougos, K Eftychia - Novel Frontiers of Advanced …, 2013 - intechopen.com
Early and accurate diagnosis of patients with cerebral demyelinating or infection diseases,
space occupying mass lesions and neurological deficits, is essential for optimum treatment …

High-field MR spectroscopy in the multiparametric MRI evaluation of breast lesions

C Cavedon, G Meliadò, L Rossi, L Camera, I Baglio… - Physica Medica, 2016 - Elsevier
Introduction The aim of this work was to assess the role of 3T-MR spectroscopy (MRS) in the
multi-parametric MRI evaluation of breast lesions, using a pattern-recognition based …